Page last updated: 2024-09-04

olmesartan and isosorbide-5-mononitrate

olmesartan has been researched along with isosorbide-5-mononitrate in 1 studies

Compound Research Comparison

Studies (olmesartan)	Trials (olmesartan)	Recent Studies (post-2010) (olmesartan)	Studies (isosorbide-5-mononitrate)	Trials (isosorbide-5-mononitrate)	Recent Studies (post-2010) (isosorbide-5-mononitrate)
841	185	554	882	369	117

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, M; Jiang, Z; Li, Y; Peng, Y; Shi, S; Song, J	1

Other Studies

1 other study(ies) available for olmesartan and isosorbide-5-mononitrate

Article	Year
High-dose nitrate therapy recovers the expression of subtypes α BMC cardiovascular disorders, 2020, 02-27, Volume: 20, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Imidazoles; Isosorbide Dinitrate; Kidney Cortex; Male; Myocardial Infarction; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors	2020

Article

Year

High-dose nitrate therapy recovers the expression of subtypes α

BMC cardiovascular disorders, 2020, 02-27, Volume: 20, Issue:1

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Drug Therapy, Combination; Heart Failure; Imidazoles; Isosorbide Dinitrate; Kidney Cortex; Male; Myocardial Infarction; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors

2020